ProCE Banner Activity

CME

Lessons Learned on Long-Acting ART: Implementation Insights From European Pioneers

Multimedia
Hear from a panel of pioneering European healthcare professionals and a patient receiving long-acting ART as they share the latest data and recommendations and discuss their experiences, practical insights, and recommendations for implementing long-acting ART into practice.

Physicians: Maximum of 1.50 AMA PRA Category 1 Credits™

Released: January 20, 2023

Expiration: January 19, 2024

Share

Faculty

Tom

Tom ,

Stephane De Wit

Stephane De Wit, MD, PhD

Former Head
Infectious Diseases
Saint Pierre University Hospital
Brussels, Belgium

Eric Florence

Eric Florence, MD, PhD

Internal Medicine, Infectious Diseases & Tropical Medicine
University Hospital of Antwerp
Edegem, Brussels

Mireia SantaCreu Guerrero

Mireia SantaCreu Guerrero, MSN

Research Nurse/Study Coordinator
HIV Unit
Hospital 12 de Octubre
I+12 Investigation Institute Foundation
Madrid, Spain

Laurence Slama

Laurence Slama, MD, PhD

Doctor
Department of Infectious Diseases
Hôtel Dieu, APHP
Paris, France

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

ViiV Healthcare

Target Audience

This program is intended for physicians and other members of the healthcare team who provide care for patients with HIV infection.

Learning Objectives

  • Apply a thorough understanding of available data and real-world experience to ensure that long-acting ART is considered as a treatment strategy for patients for whom it may be appropriate
  • Integrate strategies to administer long-acting ART, support patient adherence to dosing visits, and minimize barriers to uptake and adverse events
  • Counsel colleagues and patients regarding potential future long-acting ART regimens and their anticipated availability

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty Disclosure

Primary Author

Tom ,

Tom has no relevant financial relationships to disclose.

Stephane De Wit, MD, PhD

Former Head
Infectious Diseases
Saint Pierre University Hospital
Brussels, Belgium

Stephane De Wit, MD, PhD, has no relevant financial relationships to disclose.

Eric Florence, MD, PhD

Internal Medicine, Infectious Diseases & Tropical Medicine
University Hospital of Antwerp
Edegem, Brussels

Eric Florence, MD, PhD: researcher (paid to institution): Gilead Sciences, Merck Sharpe & Dohme, ViiV Healthcare; consultant/advisor/speaker (paid to institution): Gilead Sciences, ViiV Healthcare; other/travel grant: ViiV Healthcare.

Mireia SantaCreu Guerrero, MSN

Research Nurse/Study Coordinator
HIV Unit
Hospital 12 de Octubre
I+12 Investigation Institute Foundation
Madrid, Spain

Mireia SantaCreu Guerrero, MSN: consultant/advisor/speaker: GlaxoSmithKline, ViiV Healthcare.

Laurence Slama, MD, PhD

Doctor
Department of Infectious Diseases
Hôtel Dieu, APHP
Paris, France

Laurence Slama, MD, PhD: consultant/advisor/speaker: Gilead Sciences, Merck Sharpe & Dohme, ViiV Healthcare; researcher: ViiV Healthcare.

Instructions for Credit

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Information

Participation in this self-study activity should be completed in approximately 1.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 20, 2023, through January 19, 2024:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 100.00% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve healthcare professionals’ competence in integrating current and future long-acting ART agents into clinical practice, including strategies related to healthcare service delivery, patient counseling, and healthcare professional training.